Latest filing published 04 Feb 2026 for aTYR PHARMA INC.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +175.3%Entry US$1.98 · Close at T+365 US$5.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nancy Denyes: trading record in brief
Nancy Denyes discloses dealings in aTYR PHARMA Inc to SEC (Form 4). We count 8 filings; the first trade dates from 16 May 2020 and the latest from 3 February 2026.
On the open market, the record shows 1 purchase worth €8,530 and 2 sales worth €4,352. Purchases outweigh sales by €4,178. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 option exercises.
On 4 February 2026 came the latest disclosure, an option exercise in aTYR PHARMA Inc. The latest purchase dates back some time: it was published 885 days ago, on 6 June 2024. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Nancy Denyes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,687 sharesCommon StockSEC:0001193125-26-037996:0
- 899 shares@ US$3.78Common StockSEC:0000950170-25-013878:1
- 2,687 sharesCommon StockSEC:0000950170-25-013878:0
- 5,000 shares@ US$1.8552100.0% of flowCommon StockSEC:0000950170-24-069680:0Canonical exit: 3 Sept 2024 (T+90)
- 2,688 sharesCommon stockSEC:0001209191-24-002945:0
- 2,688 sharesCommon stockSEC:0001209191-23-007367:0
- 892 sharesCommon StockSEC:0001209191-20-032794:0
- 322 shares@ US$3.62Common StockSEC:0001209191-20-032794:1
8 of 8 declarations